Iridology Course


This course has been given by Professor Bryan K Marcia

This is an interesting and interactive course that enables the student to interact with one of the world’s most active researchers in Iridology and Sclerology, Professor Bryan Marcia who earned his Ph.D. in Iridology in the US. Students taking this course will be able to really immerse themselves in thousands of images of human irides, along with many real case histories. It will also be an honour and privilege to interact with one of the world’s mentors in iridology who will share their clinical experience with an open mind and a big, warm heart.

The course is comprised of 15 levels, with comprehensive exams at the end of each level that can be taken online. The 15 levels include:

Level One - Introduction to Iridology
This first level introduces the roots of Iridology going back to findings in Tutankhamen's tomb toward current technological advancements and developments. Results obtained by scientists especially during the last 15-20 years have increased considerably our knowledge about the eyes complex exteroceptive areas of reflected information, associated with the cerebral centers.

Level Two - Anatomy of the Eye - Iris Exam Procedures
This level covers basic anatomical fundamentals of the whole eye. Other anatomical principles covered include the anterior part of the eye, histology, bio-microscopic characteristics of the iris surface, physiological functions of the iris, pathology of the anterior part of the eye, inborn anomalies of the iris, diseases of the iris, benign tumors of the iris and common pathology of the structures of the anterior eye will be reviewed.

Level Three - Integrative Iridology Chart
One of the most controversial questions in iridology is the vast amount (40 Plus) of Iridology charts. It has been distinguished that around 70% of iridology charts correspond with each other and around 25% have unique differences. Students are shown how such topographical chart differences can be justified by learning important factors. Several Iridology charts from past centuries are shown to familiarize the student with Iridology chart development. This level also covers detailed integrative medicine recommendations for every topographic iris sector.

Level Four - Structural Signs of the Iris
Structural, reflex and pigment pathological signs are most informative iridological signs. Students will discover how they provide the information about the location of the pathological process, and allow, as far as it is possible in iridology to evaluate their mechanism, stage, character and severity.

Level Five - Constitutional Classification Via the Iris
This discipline will expose the student to numerous variations of iris constitutions and associated treatment principles. From the standpoint of prevention, the identification of a disease process in the pre-clinical phase is more desirable than long-term therapy for damaged organs and tissue systems. This can be achieved by accurately identifying the constitution and the reactive capabilities of the patient with consideration of environmental and stress factors.

Level Six - The Autonomic Nerve Wreath
The autonomic nerve wreath (ANW) is the projection of autonomous (vegetative) nervous system. Students will discover how the Autonomic Nerve Wreath has dual origin: embryological (from fetal membranes) and vascular (from the vessels of the lesser arterial circle). The autonomic nerve wreath is individual for each person; however, students will be shown that it is possible to distinguish several typical forms including its iridodiagnostic significance in detecting active genetic weaknesses.

Level Seven - Pupils and Pupillary Symptoms
The student will learn how pupil reflexes play the primary role in making diagnosis of many neurological diseases, being a part of well-known syndromes: Bernard-Horner, Adie's, Argylle-Robertson, Parinoud's etc. Students will discover how changes of color, dimensions, shape, position of center, equality and reflector reactions of pupils can have clinical analysis significance.

Level Eight - Toxic Dystrophic Signs of the Iris
In this study, the student will learn about the group of toxic dystrophic changes of iris and how Iridodiagnostic tests make it possible to evaluate many toxic-dystrophic processes. Students will also discover how toxic-dystrophic signs are symptoms of organism changes and how to offer pertinent lifestyle recommendations.

Level Nine - Heterochromias of the Iris
Students will learn about heterochromias of iris and differentiation between inherited and acquired diffuse and local changes of color. Students will discover the importance of hereditary peculiarities of iris color, toxic and drug dyschromias, pigment spots and their color, tints of iris stroma and why they should be carefully analyzed.

Level Ten - Adaptive Rings and Arcs
Ophthalmologists consider contraction rings to be the simple folds of the iris, and explain their origination by the work of neuro-motor apparatus of the eye and its contraction, dilation of the superficial layers in the iris. However, iridologists believe that some other factors should be taken into consideration since not everyone has such rings and arcs! This level will explore several theories why such rings and arcs occur in the iris.

Level Eleven - Pigment spots in the Iris
It is considered that pigment spots always point to the pathological process in the organism thereby they belong to the very important topic diagnostic signs of iris. Students will learn how residual spots are indicative of the end of pathological process in the associated organ and how their colors, size, form, density are important indicators for clinical evaluation.

Level Twelve - Conjunctiva Signs
The Student will learn how evaluation of bulbar conjunctiva does not duplicate the iridodiagnostic examination but can offer entirely new data to the results of iridodiagnostics.

Level Thirteen - Iridological Axis Signs
Axis signs consist of a group of markers consisting of lacuna, crypts, radial furrows, pigment and collarette signs found in specific locations in the eye. The student shall learn how to recognize possible irido-reflex markers in the eye.

Level Fourteen – Transversals in the Iris
Transversals are very important focus signs in the iris for the student to learn. Transversals can point to possible tissue change and congestion in the corresponding organ. Students will review actual clinical examples of the several possible types of transversals that can appear in the iris.

Level 15 - Iridodiagnostic Examination Procedures
Students will learn how iridodiagnostic conclusion is made according to the appearance of the iris and its signs, thereby basing iridodiagnostic methods on visual and iridoscopic examination of the iris. Devices used for iridological examination procedures including expert evaluation of iris signs are covered in great detail.

*All courses include three iridological charts, student web server database access (on-line videos, case studies, searchable databases), lifetime account access.

Course Requirements
There will be some additional reading material and time spent researching the many resources on the website. Studying some of the case histories is also important. The serious professional would also be interested in investing a little more and buying a professional iridoscope that will enable you to capture your patient’s irides on the computer screen and analyze and diagnose using sophisticated software which also produces professional reports for your patients to take away with them.

Course Goals and Objectives
This course will present a comprehensive overview of the Iridological sciences while exploring the continuum of research & development ranging from existing Iridodiagnostic principles to current theories and applications. Students will additionally explore the implications of utilizing Iridology as an adjunctive diagnostic modality in North America. This course will examine contemporary issues such as the relationship between North American Iris Analysis and several European-Asian Iridodiagnostic principles.

The student shall be able to demonstrate knowledge about Iridology in both historical and contemporary context.

To have the student understand the Central Hypotheses of Iridology.

Expose students to specific techniques of iris reading and begin to practice using a magnifying lens, camera systems and digital iriscope systems.

To instruct students with difficult iris analysis techniques such as brown and highly pigmented eyes.

To teach how pupil reflexes play a primary role in many neurological diseases.

Assist the student in understanding the similarity and differences between American/Jensen Iridology research and current research accomplished in Europe and Asia.

Students will study modern concepts of physiology and doctrine regarding nerve activity and theories.

Students will discover the significance of the eccentric adaptive rings in the iris.

Students will discover the iridodiagnostic significance in detecting a genetically active weakness via the Autonomic Nerve Wreath.

The student will learn about the classifications of toxic dystrophic changes of iris.

Students will discover how structural, reflex and pigment pathological signs are the most informative Iridological signs regarding the location of certain pathological processes in the body.

Students will identify changes of pupil color, dimensions, shape, position, equality and reflector reactions and their clinical significance.

Students will learn how residual spots found in the iris are indicative of the end of pathological process of an associated organ.

Students will learn how visible changes of conjunctiva vessels, crystalline, cornea can add to Iridological conclusions.

Students will discover the importance of hereditary peculiarities in iris color including toxic and drug dyschromias, pigment spots and their color.

To expose the student to numerous variations of iris constitutions and associated treatment principles.

To offer student clinical and educational forms for use in clinical practice.

To maintain student motivation and activity throughout their course learning process.

To expose the student to the most current Iridological research developments.

To guide students through complete iris analysis.

To have the student successfully pass examinations.

Course Materials
All the course material required to complete this course is contained in this course. This will include CDs and DVDs that will load the complete course onto your computer so that you can access it anywhere in the world. Once installed, there are many interactive links that enable you to research to your hearts content many aspects of iridology and sclerology. The serious practitioner will also want to order the iridoscope with computer software to begin examining their patient’s irides immediately.

Grading Policy
Each lesson is followed by an end of lesson exam which will be based on material covered in the lesson.

Recommended Books
All course material is given online. There are no required books for this course but here are a few recommended titles for additional study.

What is Iridology?

Iridology is the study of the iris of the eye.

There are many theories on how Iridology indicates what is going on in the body. To understand the theories you may also want to research reflexology, acupressure and acupuncture.

One is a theory that there are hundreds of thousands of nerves or energies running from every tissue and organ of the body, ending in the tips of your fingers and toes as well as the iris of your eyes. That is why stubbing your toes hurts more than the same impact on the leg.

Nature is somewhat constant. Most people know that when the roots of a plant have been injured or aren't receiving the nutrients or moisture that they need, the first signs of the decline in the health of the plant will be found in the outer most part of the leaves.

Apply that to the nerve endings that are running throughout your body. If, for instance, your pancreas has been damaged or lacking a nutrient or is in poor health, the first sign of the decline in the health of the pancreas will be found in the outermost part of the nerve endings, many which end in the iris of the eye.

Though exact neurological mechanics of the phenomenon is not fully understood, it seems that when an organ or body system is in poor health the nerve running from that body part will start to recede, somewhat like a leaf wilts. When it does, it draws with it various degrees of the layers of fibers which make up the color of the iris of the eyes, leaving darkened marks called lesions.

Traditional medicine

What is traditional medicine?

Traditional medicine refers to health practices, approaches, knowledge and beliefs incorporating plant, animal and mineral based medicines, spiritual therapies, manual techniques and exercises, applied singularly or in combination to treat, diagnose and prevent illnesses or maintain well-being.

Countries in Africa, Asia and Latin America use traditional medicine (TM) to help meet some of their primary health care needs. In Africa, up to 80% of the population uses traditional medicine for primary health care. In industralized countries, adaptations of traditional medicine are termed “Complementary“ or “Alternative” (CAM).

Increasing use and popularity

TM has maintained its popularity in all regions of the developing world and its use is rapidly spreading in industrialized countries.

In China, traditional herbal preparations account for 30%-50% of the total medicinal consumption.
In Ghana, Mali, Nigeria and Zambia, the first line of treatment for 60% of children with high fever resulting from malaria is the use of herbal medicines at home.
WHO estimates that in several African countries traditional birth attendants assist in the majority of births.
In Europe, North America and other industrialized regions, over 50% of the population have used complementary or alternative medicine at least once.
In San Francisco, London and South Africa, 75% of people living with HIV/AIDS use TM/CAM.
70% of the population in Canada have used complementary medicine at least once.
In Germany, 90% of the population have used a natural remedy at some point in their life. Between 1995 and 2000, the number of doctors who had undergone special training in natural remedy medicine had almost doubled to 10 800.
In the United States, 158 million of the adult population use complementary medicines and according to the USA Commission for Alternative and Complementary medicines, US $17 billion was spent on traditional remedies in 2000.
In the United Kingdom, annual expenditure on alternative medicine is US$ 230 million.
The global market for herbal medicines currently stands at over US $ 60 billion annually and is growing steadily.
Safety and efficacy issues

Scientific evidence from randomized clinical trials is only strong for many uses of acupuncture, some herbal medicines and for some of the manual therapies. Further research is needed to ascertain the efficacy and safety of several other practices and medicinal plants.

Unregulated or inappropriate use of traditional medicines and practices can have negative or dangerous effects.

For instance, the herb “Ma Huang” ( ) is traditionally used in China to treat respiratory congestion. In the United States, the herb was marketed as a dietary aid, whose over dosage led to at least a dozen deaths, heart attacks and strokes.

In Belgium, at least 70 people required renal transplant or dialysis for interstitial fibrosis of the kidney after taking a herbal preparation made from the wrong species of plant as slimming treatment.

Biodiversity and sustainability

In addition to patient safety issues, there is the risk that a growing herbal market and its great commercial benefit might pose a threat to biodiversity through the over harvesting of the raw material for herbal medicines and other natural health care products. These practices, if not controlled, may lead to the extinction of endangered species and the destruction of natural habitats and resources.

Another related issue is that at present, the requirements for protection provided under international standards for patent law and by most national conventional patent laws are inadequate to protect traditional knowledge and biodiversity.

Tried and tested methods and products

25% of modern medicines are made from plants first used traditionally.
Acupuncture has been proven effective in relieving postoperative pain, nausea during pregnancy, nausea and vomiting resulting from chemotherapy, and dental pain with extremely low side effects. It can also alleviate anxiety, panic disorders and insomnia.
Yoga can reduce asthma attacks while Tai Ji techniques can help the elderly reduce their fear of falls.
TM can also have impact on infectious diseases. For example, the Chinese herbal remedy Artemisia annua, used in China for almost 2000 years has been found to be effective against resistant malaria and could create a breakthrough in preventing almost one million deaths annually, most of them children, from severe malaria.
In South Africa, the Medical Research Council is conducting studies on the efficacy of the plant Sutherlandia Microphylla in treating AIDS patients. Traditionally used as a tonic, this plant may increase energy, appetite and body mass in people living with HIV.
WHO efforts in promoting safe, effective and affordable traditional medicine

The World Health Organization launched its first ever comprehensive traditional medicine strategy in 2002. The strategy is designed to assist countries to:

Develop national policies on the evaluation and regulation of TM/CAM practices;
Create a stronger evidence base on the safety, efficacy and quality of the TAM/CAM products and practices;
Ensure availability and affordability of TM/CAM including essential herbal medicines;
Promote therapeutically sound use of TM/CAM by providers and consumers;
Document traditional medicines and remedies.
At present, WHO is supporting clinical studies on antimalarials in three African countries; the studies are revealing good potential for herbal antimalarials.

Other collaboration is taking place with Burkina Faso, the Democratic Republic of the Congo, Ghana, Mali, Nigeria, Kenya, Uganda, and Zimbabwe in the research and evaluation of herbal treatments for HIV/ AIDS, malaria, sickle cell anaemia and Diabetes Mellitus.

In Tanzania, WHO, in collaboration with China, is providing technical support to the government for the production of antimalarials derived from the Chinese herb Artemisia annua. Local production of the medicine will bring the price of one dose down from US $6 or $7 to a more affordable $2.

In 2003, WHO support has so far facilitated the development and introduction of traditional and alternative health care curricula in seven tertiary education institutions in the Philippines.

Training workshops on the use of traditional medicines for selected diseases and disorders have also been organized in China, Mongolia and Vietnam.

Priorities for promoting the use of traditional medicines

Over one-third of the population in developing countries lack access to essential medicines. The provision of safe and effective TM/CAM therapies could become a critical tool to increase access to health care.

While China, the Democratic People’s Republic of Korea, the Republic of Korea and Vietnam have fully integrated traditional medicine into their health care systems, many countries are yet to collect and integrate standardized evidence on this type of health care.

70 countries have a national regulation on herbal medicines but the legislative control of medicinal plants has not evolved around a structured model. This is because medicinal products or herbs are defined differently in different countries and diverse approaches have been adopted with regard to licensing, dispensing, manufacturing and trading.

The limited scientific evidence about TM/CAM’s safety and efficacy as well as other considerations make it important for governments to:

Formulate national policy and regulation for the proper use of TM/CAM and its integration into national health care systems in line with the provisions of the WHO strategies on Traditional Medicines;
Establish regulatory mechanisms to control the safety and quality of products and of TM/CAM practice;
Create awareness about safe and effective TM/CAM therapies among the public and consumers;
Cultivate and conserve medicinal plants to ensure their sustainable use.
Recommendations by WHO and EU
The WHO Traditional Medicines Strategy 2002-2005 outlines the role and activities in traditional medicines / complementary and alternative medicine (TM/CAM) (ref 1). The strategy incorporates four objectives, two of which focus on safety:

Policy – Integrate TM/CAM with national health care systems, as appropriate, by developing and implementing national TM/CAM policies and programmes.
Safety, efficacy and quality – Promote the safety, efficacy and quality of TM/CAM by expanding the knowledge-base on TM/CAM, and by providing guidance on regulatory and quality assurance standards.
The European Union (EU) treaty came into force on November 1 1993. The treaty was intended to open a large market zone without borders, enabling the free movement of persons, goods, services, and capital. The treaty’s regulation of movement of persons and goods affects in particular health service and medications. WHO gives the following description in the "Legal status of TM/CAM: A worldwide review":

Although the free movement of persons within the European Union is the cornerstone of the Treaty of Rome, the diversity of national policies severely limits its applicability to practitioners of CAM. Case 61/89 of the European Court of Justice involved an acupuncturist without allopathic medical qualifications practising in France. The courts decision confirmed the right of individual countries to make their own legislation on whether or not to reserve the practice of medicine to allopathic doctors.
Nonetheless, in April 1994, European Deputy Paul Lannoye presented a proposal on the status of CAM to the European Parliament Committee on the Environment, Public Health, and Consumers Protection. He asked for provisions for CAM within social security systems, the incorporation of CAM into the European Pharmacopoeia, an end to prosecutions of non-allopathic practitioners in the countries where the practise of medicine is the exclusive domain of allopathic providers, and a pan-European system of recognition and regulation of CAM practitioners along the lines of the British Osteopath and Chiropractor Acts. He also requested a research budget of 10 million Euros per year for five years. At the last moment the European Parliament cancelled the vote on the proposal (ref 2).
In May 1997 The European Parliament adopted a resolution on the status of non-conventional medicine (ref 3). The resolution called the Commission to:

Launch a process of recognising non-conventional medicine.
Carry out a thorough study into safety, effectiveness, area of application and the complementary or alternative nature of all non-conventional medicines with a view to their eventual legal recognition….
Draw up a comparative study of the various national legal models to which non-conventional medical practitioners are subject….
In formulating European legislation … make clear distinction between non-conventional medicines that are "complementary" in nature and those which are "alternative" medicines in the sense that they replace conventional medicine…
A resolution of the European Parliament, however, is not a binding act, but a declaration of policy. Nonetheless, the adoption of the resolution has led several countries to consider revising legislation (ref 4).

Concerning CAM providers and CAM therapies, an EU resolution in 1999 stated:

" In the health field, it is important to preserve the diversity of national legislation and practise that is one of Europe’s assets: people’s attachment to their own systems and tradition must not be called into question. Nevertheless, the Assembly believes that a common European approach to non-conventional medicine based on the principle of patients’ freedom of choice in health care should not be ruled out."
" The Assembly believes that the best guarantee for patients lies in a properly trained profession, which is aware of its limitations, has a system of ethics and self-regulation and is also subject to outside control." (ref 5)
This resolution and case 61/89 of the European Court of Justice gave the members of the European Union the opportunity to regulate CAM therapies and providers according to health legislation and CAM tradition in their own countries.

The EU parliament has, since 1994, adopted several directives regulating the trade of herbal products. Two directives concerning homeopathy came into force on January 1994: one applicable for homeopathic products for humans and one applicable for homeopathic veterinary products. The directive on traditional herbal medical products will be in force from 1 November 2005 (2004/24/EC), and the directive on food supplements was set in force from 1 August 2005 (Vitamins & Minerals, 2002/46/EC). These directives will be adopted in the legislation of the European countries and will thus harmonize the regulation of herbal products and food supplements.

1. WHO, Traditional Medicine Strategy 2002-2005 (document WHO/EDM/TRM/2002.1). Geneva: World Health Organization, 2002.

2. Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review, (document WHO/EDM/TRM/2001.2). Geneva: World Health Organization, 2001: s 188.

3. European Parliament, Resolution A4 1997/0075.

4. Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review, (document WHO/EDM/TRM/2001.2). Geneva: World Health Organization, 2001.

5. European Parliament Resolution 1999/1206